MMM
REGN icon

Mendel Money Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Mendel Money Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-273
Closed -$263K – 134
2024
Q1 		$263K Buy
273
+1
+0.4% +$951 0.12% 117
2023
Q4 		$239K Sell
272
-18
-6% -$14.8K 0.11% 121
2023
Q3 		$239K Hold
290
– – 0.13% 118
2023
Q2 		$208K Hold
290
– – 0.11% 122
2023
Q1 		$238K Sell
290
-10
-3% -$7.54K 0.13% 119
2022
Q4 		$216K Sell
300
-4
-1% -$2.95K 0.12% 118
2022
Q3 		$209K Buy
+304
New +$191K 0.13% 112
2022
Q2 		– Sell
-307
Closed -$214K – 121
2022
Q1 		$214K Buy
+307
New +$194K 0.1% 120

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return